C. Nazaret

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
C Nazaret, C. Nazaret, Corinne Nazaret
Publication record
44 papers · 840 citations · H-index 13

PAPERS

Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet.
201486 citationsauthor #7
Mo1990 Intestinal Lepr-B Specific Signalling Is Required for Full Expression and Activity of Sugar Transporters
20131 citationsauthor #4
T1923 Oral Leptin Induces Glut5 mRNA and Potentiates These Levels in Mice Fed a Hypercaloric Meal
20100 citationsauthor #2
592 The Facilitative Glucose Transporter GLUT-2 Is Up-Regulated By Mucosal Leptin Through AMPK Involved Mechanisms in the Small Intestine
20090 citationsauthor #3
Resistin-Like Molecule-β Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport
200938 citationsauthor #4
Reduced Intestinal Absorption of Dipeptides via PepT1 in Mice with Diet-induced Obesity Is Associated with Leptin Receptor Down-regulation*
200945 citationsauthor #6
Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents
200972 citationsauthor #2
Modulation of Dextran Sulphate Sodium-Induced Colonic Inflammation by Local Supplementation of Leptin~!2008-08-10~!2008-10-20~!2008-12-05~!
20080 citationsauthor #1
Distinction between bumetanide-sites at rat Na-K-Cl cotransporters BSC1 and BSC2
19990 citationsauthor #3
The erythrocyte Na,K,Cl cotransporter and its circulating inhibitor in Dahl salt‐sensitive rats
199812 citationsauthor #2
F008 Erythrocyte Na$z.sbnd;K$z.sbnd;Cl cotransporter NKCCl isoform in Dahl salt-sensitive rats
19980 citationsauthor #2
Regulation of renal Na-K-Cl cotransporter NKCC2 by humoral natriuretic factors: relevance in hypertension.
199811 citationsauthor #4
Endogenous sodium-potassium-chloride cotransport inhibitor in congestive heart failure.
19968 citationsauthor #4
948–53 A New Natriuretic Factor Acting Like Loop Diuretic Drugs in Heart Failure. Relation to the Severity of Left Ventricular Dysfunction
19951 citationsauthor #4
Inhibition of Na-K-Cl cotransport fluxes and salidiuretic action by an urinary extract of salt-loaded rats
19941 citationsauthor #5
[A new natriuretic factor acting like loop diuretics. Kinetics in normal and hypertensive rats].
19940 citationsauthor #5
Opposite effects of cell growth factors and cicletanine sulfate on the sodium-independent [Cl-/HCO3-] exchange in cultured vascular smooth muscle.
19933 citationsauthor #2
Cicletanine sulfate: inhibition of anion transport systems and natriuretic activity
19924 citationsauthor #3
[Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases].
199215 citationsauthor #4
Dissociation between derepressed K+,Cl- cotransport system and high blood pressure in the F2 hybrid generation (SHR x WKY).
19914 citationsauthor #2
Evidence for the O-sulfo derivative of MK-447 as active metabolite of MK-447.
19914 citationsauthor #2
Evidence for a sulfo-conjugate as active metabolite of cicletanine.
19910 citationsauthor #3
CRE 10904 [2-(p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: a new diuretic and antihypertensive drug acting by in vivo sulfation.
199021 citationsauthor #4
Stimulation of Na(+)-H+ exchange, the Na(+)-K+ pump and Na+,K+,Cl- cotransport by endothelin-1 in cultured vascular smooth muscle cells.
19897 citationsauthor #3
Demonstration of a [K+,Cl-]-cotransport system in human red cells by its sensitivity to [(dihydroindenyl)oxy]alkanoic acids: regulation of cell swelling and distinction from the bumetanide-sensitive [Na+,K+,Cl-]-cotransport system.
1988159 citationsauthor #2
Inhibition of the Cl-/NaCO3- anion exchanger by xipamide in human red blood cells.
198711 citationsauthor #1
Correlation between Blood Pressure and K+ Fluxes in Essential Hypertensive Patients Treated For 2 Years with Cicletanine
19870 citationsauthor #3
The significance of the relative effects of loop diuretics and anti-brain edema agents on the Na+, K+, Cl− cotransport system and the Cl−/NaCO3− anion exchanger
198610 citationsauthor #3
Interaction of BN 52021 and PAF-acether with membrane ion transport
19850 citationsauthor #4
Na+ leak in erythrocytes from essential hypertensive patients.
198526 citationsauthor #2
The interaction of canrenone with the Na+,K+ pump in human red blood cells
19858 citationsauthor #3
The effect of cyclic AMP on Na+ and K+ transport systems in mouse macrophages
19852 citationsauthor #4
Involvement of cytosolic free calcium in the action mechanism of atrial natriuretic factor (ANF).
19853 citationsauthor #8
Involvement of natriuretic hormones and Na+ transport in the antihypertensive action of canrenone.
19852 citationsauthor #4
A classification of essential hypertensive patients according to the erythrocyte Na transport abnormalities: an application for monitoring the antihypertensive response to cicletanide.
19853 citationsauthor #2
Are icosanoids involved in ion transport regulation? A possible role in essential hypertension
19841 citationsauthor #3
The effects of cyclic nucleotides and eicosanoids on Na+ and K+ transport systems in human red cells and mouse macrophages.
19842 citationsauthor #3
Stimulation of K+ fluxes by diuretic drugs in human red cells.
198467 citationsauthor #2
The effect of icosanoids and cyclic nucleotides on Na+ and K+ transport in human red cells (HRC) and mouse elicited peritoneal macrophages (MM)
19840 citationsauthor #3
Abnormal Na+K+ cotransport function in a group of patients with essential hypertension
198380 citationsauthor #2
The effect of cyclic nucleotides and icosanoids on Na+ and K+ transport in human red cells.
19832 citationsauthor #2
A genetic approach to the geography of hypertension : examination of Na+ - K+ cotransport in Ivory Coast Africans.
198142 citationsauthor #2
Abnormal erythrocyte Na+ K+ cotransport system, a proposed genetic marker of essential hypertension.
198123 citationsauthor #4
Inheritance of abnormal erythrocyte cation transport in essential hypertension.
198166 citationsauthor #3

TIMELINE

1981 131 citations

1983 82 citations

1984 70 citations

1985 44 citations

1986 10 citations

1987 11 citations

1988 159 citations

1989 7 citations

1990 21 citations

1991 8 citations

1992 19 citations

1993 3 citations

1994 1 citations

1995 1 citations

1996 8 citations

1998 23 citations

1999 0 citations

2008 0 citations

2009 155 citations

2010 0 citations

2013 1 citations

2014 86 citations

C. Nazaret

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT